ENZON PHARMACEUTICALS, INC. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Enzon Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was 3.22 %, a 46.3% increase year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Return On Assets for 2023 was 2.92 %.
  • Enzon Pharmaceuticals, Inc. annual Return On Assets for 2022 was -0.39 %, a 59.4% increase from 2021.
  • Enzon Pharmaceuticals, Inc. annual Return On Assets for 2021 was -0.98 %, a 87.6% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 2.92 +3.32 Jan 1, 2023 Dec 31, 2023
2022 -0.39 +0.58 +59.4% Jan 1, 2022 Dec 31, 2022
2021 -0.98 +6.93 +87.6% Jan 1, 2021 Dec 31, 2021
2020 -7.91 +1.09 +12.1% Jan 1, 2020 Dec 31, 2020
2019 -9 -64 -116% Jan 1, 2019 Dec 31, 2019
2018 55 +7.12 +14.9% Jan 1, 2018 Dec 31, 2018
2017 47.9 +54 Jan 1, 2017 Dec 31, 2017
2016 -6.11 -76.2 -109% Jan 1, 2016 Dec 31, 2016
2015 70.1 -43.4 -38.2% Jan 1, 2015 Dec 31, 2015
2014 114 +84.3 +289% Jan 1, 2014 Dec 31, 2014
2013 29.2 +30.1 Jan 1, 2013 Dec 31, 2013
2012 -0.96 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.